SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-055054
Filing Date
2014-08-29
Accepted
2014-08-29 16:39:57
Documents
1
Period of Report
2014-08-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9876
  Complete submission text file 0001209191-14-055054.txt   12158
Mailing Address One Embarcadero Center San Francisco CA 94111
Business Address One Embarcadero Center San Francisco CA 94111 415-352-1520
CMEA Ventures VII LP (Reporting) CIK: 0001405712 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-36292 | Film No.: 141075694

Mailing Address C/O CMEA VENTURES VII GP LP ONE EMBARCADERO CENTER, SUITE 3250 SAN FRANCISCO CA 94111
Business Address C/O CMEA VENTURES VII GP LP ONE EMBARCADERO CENTER, SUITE 3250 SAN FRANCISCO CA 94111 415-352-1520
CMEA VENTURES VII (PARALLEL) LP (Reporting) CIK: 0001405972 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-36292 | Film No.: 141075693

Mailing Address 3366 N. TORREY PINES COURT SUITE 225 LA JOLLA CA 92037
Business Address 3366 N. TORREY PINES COURT SUITE 225 LA JOLLA CA 92037 (858) 558-2400
Auspex Pharmaceuticals, Inc. (Issuer) CIK: 0001454189 (see all company filings)

IRS No.: 954862842 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations